Found 0 matching trials
A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With Acromegaly PHASE3 he purpose of this study is to evaluate the efficacy and safety of SYHX2008...
Show More Location
Multiple Locations
Learn More & Join Trial
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly PHASE2 The purpose of this study is to compare the efficacy of Sandostatin LAR® (R...
Show More Location
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Learn More & Join Trial
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly PHASE3 A multicentre, prospective, open label study of acromegalic patients evalua...
Show More Location
Klinikum Innenstadt
Learn More & Join Trial
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. PHASE4 Study to allow access to everolimus for patients who are on everolimus trea...
Show More Location
Hematology Oncology Services of Arkansas SC
Learn More & Join Trial
Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease PHASE3 The purpose of this randomized, multicenter, Phase III study was to compare...
Show More Location
Scottsdale Healthcare/TGen Clinical Research Service TGen Clinical Research Service
Learn More & Join Trial
A Study to Assess the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Debio 4126 in Participants With Acromegaly or Functioning Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) PHASE1 This is an open-label, single treatment arm, multicenter study to assess th...
Show More Location
Rigshospitalet, Endokrinologisk afdeling
Learn More & Join Trial
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma PHASE3 A preliminary study has shown that the hormone-similar, growth-retarding dr...
Show More Location
University Medical Center Freiburg
Learn More & Join Trial
Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut PHASE3 Placebo-controlled prospective randomized phase III study to investigate th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy of Medical Treatment With SOM230 LAR in Patients With Primary Inoperable Thymoma and/or With Local Recurrent Thymoma to Reduce Tumor Size PHASE2 This is a monocenter, single-arm, open label phase II trial evaluating the ...
Show More Location
Klinik und Poliklinik für Neurologie der Universität Regensburg
Learn More & Join Trial
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. PHASE3 Phase III study comparing monthly octreotide i.m. in comparison to no addit...
Show More Learn More & Join Trial